Healthcare · NIFTY 500

Acutaas Chemicals Limited

NSEACUTAAS BSE543349 ISININE00FF01025 SeriesEQ Listed on NSE · BSE

₹3,996.10 +79.20 (+2.02%) Updated 12 Nov, 8:19 pm IST

Open chart Back to screener

Price, daily close+106.43% in a year

Today

Open: ₹3,947.00
Prev close: ₹3,916.90
Day high: ₹4,120.00
Day low: ₹3,902.20
Volume: 8.86 L
Value traded: ₹357.91 Cr
Upper circuit: ₹4,700.20
Lower circuit: ₹3,133.60
52W high: ₹4,045.30
52W low: ₹1,570.00
1 month: +23.88%
6 months: +34.74%

52W low52W high

Ratios

Key numbers

Worked out from the latest filings (Consolidated) and today's price. TTM = last four quarters.

Market cap₹32,717 Cr

P/E (TTM)74.81

P/B17.61

Book value / share₹226.87

EPS (TTM)₹53.42

ROE23.6%

Dividend yield0.06%

Dividend (12m)₹2.50 / share

Net margin (TTM)27.6%

Operating margin40.3%

Debt / equity0.00

Current ratio3.99

EV / EBITDA52.04

Sales growth (YoY qtr)+42.69%

Profit growth (YoY qtr)+73.27%

Sales CAGR 3Y+29.50%

Profit CAGR 3Y—

Shares8.19 Cr

Quarterly results

Results for each quarter

Last 12 quarters, consolidated, ₹ crore. Hover a bar to see the number.

Revenue and net profit

16616.8

Dec 23

22525.1

Mar 24

17713.9

Jun 24

24737.3

Sep 24

27545.0

Dec 24

30862.5

Mar 25

20744.3

Jun 25

30672.2

Sep 25

393108

Dec 25

433132

Mar 26

33074.3

Jun 26

437125

Sep 26

Revenue · QoQ (vs last quarter)

—+35%-21%+40%+11%+12%-33%+48%+28%+10%-24%+33%

Revenue · YoY (vs a year ago)

————+65%+37%+17%+24%+43%+40%+59%+43%

Net profit · QoQ (vs last quarter)

—+50%-45%+168%+20%+39%-29%+63%+49%+22%-44%+69%

Net profit · YoY (vs a year ago)

————+168%+148%+218%+94%+140%+111%+68%+73%

RevenueNet profitLine = trend

4.83

Dec 23

6.85

Mar 24

3.67

Jun 24

9.38

Sep 24

11.35

Dec 24

7.80

Mar 25

5.41

Jun 25

8.82

Sep 25

13.10

Dec 25

16.04

Mar 26

9.04

Jun 26

15.24

Sep 26

EPS (₹) · YoY (vs a year ago)

————+135%+14%+47%-6.0%+15%+106%+67%+73%

EPS (₹)Line = trend

₹ Cr	Dec 23	Mar 24	Jun 24	Sep 24	Dec 24	Mar 25	Jun 25	Sep 25	Dec 25	Mar 26	Jun 26	Sep 26
Revenue	166	225	177	247	275	308	207	306	393	433	330	437
Other income	3.5	1.3	1.0	8.4	1.7	5.8	15.9	9.8	4.7	11.1	1.8	5.1
Total income	170	226	178	255	277	314	223	316	398	444	331	442
Raw material	86.1	134	105	143	157	165	104	131	176	184	166	156
Purchases	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Employee cost	16.1	17.0	19.1	19.6	21.7	23.3	25.1	29.4	29.9	33.3	39.6	42.1
Other expenses	28.8	29.7	25.8	38.6	36.8	37.7	34.4	46.1	43.5	51.5	38.3	53.5
Total expenses	146	189	158	205	213	231	165	220	253	260	228	275
Operating profit	26.5	42.8	29.5	48.9	68.7	85.0	50.9	95.3	151	184	113	176
OPM %	15.9%	19.0%	16.7%	19.8%	25.0%	27.5%	24.6%	31.1%	38.3%	42.4%	34.3%	40.3%
Finance cost	2.5	2.1	4.4	0.5	0.7	0.6	0.6	0.6	0.9	1.2	1.1	1.0
Depreciation	3.8	4.9	6.2	6.8	6.3	7.3	8.1	8.4	9.8	9.6	9.8	12.7
Exceptional items	—	-0.3	—	—	—	—	—	—	—	—	—	—
Profit before tax	23.7	37.2	20.0	50.0	63.3	82.8	58.1	96.2	145	184	104	167
Tax	5.9	11.5	5.3	12.5	17.9	20.1	14.1	24.3	38.4	49.5	28.9	44.2
Net profit	17.8	25.7	14.7	37.6	45.4	62.7	44.0	71.9	106	134	75.0	123
Profit to shareholders	16.8	25.1	13.9	37.3	45.0	62.5	44.3	72.2	108	132	74.3	125
EPS (₹)	4.83	6.85	3.67	9.38	11.35	7.80	5.41	8.82	13.10	16.04	9.04	15.24

Profit & loss

Results for each year

5 financial years (April to March), consolidated, ₹ crore.

Sales, operating profit and net profit

52010571.9

FY22

6171230.0

FY23

71796.442.8

FY24

1,007232159

FY25

1,339480356

FY26

Revenue · YoY (vs a year ago)

—+19%+16%+40%+33%

Net profit · YoY (vs a year ago)

—-100%—+271%+124%

RevenueOperating profitNet profitLine = trend

₹ Cr	FY22	FY23	FY24	FY25	FY26
Revenue	520	617	717	1,007	1,339
Other income	2.8	4.3	7.5	16.9	41.6
Total expenses	431	509	611	808	898
Employee cost	41.4	48.8	63.1	83.7	118
Operating profit	105	123	96.4	232	480
OPM %	20.2%	19.9%	13.4%	23.0%	35.9%
Finance cost	6.4	2.4	5.9	6.2	3.3
Depreciation	10.1	12.3	16.1	26.6	36.0
Profit before tax	91.5	112	81.9	216	483
Tax	19.5	28.9	33.2	55.7	126
Tax rate %	21.3%	25.7%	40.5%	25.8%	26.2%
Net profit	71.9	83.3	48.7	160	356
Profit to shareholders	—	0.0	42.8	159	356
Net margin %	13.8%	0.0%	6.0%	15.8%	26.6%
EPS (₹)	21.03	22.86	11.66	19.81	43.37

Balance sheet

Assets and debt

At each year end (and the latest half year), ₹ crore.

Equity, debt and assets

5943.630.5

Mar 23

67421729.7

Mar 24

1,3108.2185

Mar 25

1,65426.5216

Mar 26

1,8575.9289

Sep 26

Shareholders' equity · YoY (vs a year ago)

—+13%+94%+26%—

Shareholders' equityBorrowingsCashLine = trend

₹ Cr	Mar 23	Mar 24	Mar 25	Mar 26	Sep 26
Shareholders' equity	594	674	1,310	1,654	1,857
Long-term borrowings	0.6	114	0.0	0.0	0.0
Short-term borrowings	3.0	103	8.2	26.5	5.9
Total borrowings	3.6	217	8.2	26.5	5.9
Current liabilities	163	285	202	231	253
Fixed assets (PPE)	222	360	505	633	1,005
Inventories	119	157	180	231	280
Trade receivables	230	206	290	363	358
Cash & equivalents	30.5	29.7	185	216	289
Current assets	470	496	792	881	1,012
Total assets	767	1,096	1,549	1,984	2,221
Debt / equity	0.01	0.32	0.01	0.02	0.00

Cash flow

Cash coming in and going out

For each financial year, ₹ crore. Free cash flow = cash from operations minus spending on fixed assets.

Operating, investing and financing cash

-8.7-124140

FY22

65.5-33.0-12.3

FY23

125-365239

FY24

118-224261

FY25

292-2664.1

FY26

Operations · YoY (vs a year ago)

—+857%+91%-5.5%+147%

OperationsInvestingFinancingLine = trend

₹ Cr	FY22	FY23	FY24	FY25	FY26
Cash from operations	-8.7	65.5	125	118	292
Cash from investing	-124	-33.0	-365	-224	-266
Cash from financing	140	-12.3	239	261	4.1
Spent on fixed assets	0.0	-96.4	-280	-195	-328
Free cash flow	-8.7	-30.9	-155	-76.3	-35.8
Net cash flow	7.6	20.2	-0.9	156	30.3

Shareholding

Who holds the shares

Promoter and public holding at each quarter end, as filed with NSE.

Holding over time

39.1%May 24

36.0%Jun 24

36.0%Sep 24

36.0%Dec 24

36.0%Mar 25

32.7%Jun 25

32.7%Sep 25

32.7%Dec 25

32.7%Mar 26

32.7%Jun 26

32.7%Sep 26

Promoter & groupPublic

Latest (30 Sep 2026)

32.7%promoter

Promoter & group: 32.66%
Public (FIIs, mutual funds, retail…): 67.34%
Promoter change, last quarter: 0.00 pts

Dividends & news

Latest dividends and announcements

Dividends & corporate actions

Dividend - Rs 2.50 Per ShareEx 17-Sep-2026
Dividend - Rs 1.50 Per ShareEx 18-Sep-2025
Face Value Split (Sub-Division) - From Rs 10/- Per Share To Rs 5/- Per ShareEx 25-Apr-2025
Annual General MeetingEx 13-Sep-2024
Dividend - Rs 3 Per ShareEx 13-Sep-2024
Annual General MeetingEx 18-Sep-2023
Dividend - Rs 3 Per ShareEx 18-Sep-2023
Annual General Meeting/Dividend - Rs 3 Per ShareEx 29-Jul-2022

Board meetings

the financial results for the period ended September 30, 202627-Oct-2026
ACUTAAS CHEMICALS LIMITED has informed the Exchange about Board Meeting to be held on 27-Oct-2026 to inter-alia consider and approve the Unaudited Fi…27-Oct-2026
ACUTAAS CHEMICALS LIMITED has informed the Exchange about Board Meeting to be held on 24-Jul-2026 to inter-alia consider and approve the Unaudited Fi…24-Jul-2026
the financial results for the period ended Jun 30, 202624-Jul-2026
the Yearly Audited Financial results of the Company for the period ended March 2026 and Dividend.30-Apr-2026

Filings with NSE

Analysts/Institutional Investor Meet/Con. Call Updates7 Nov
Updates7 Nov
Change in Management2 Nov
Analysts/Institutional Investor Meet/Con. Call Updates2 Nov
Copy of Newspaper Publication28 Oct
Analysts/Institutional Investor Meet/Con. Call Updates27 Oct
Investor Presentation27 Oct

Latest news

Why Acutaas Chemicals Share Price is RisingEquitymaster · 29 Oct, 12:30 pm Acutaas Chemicals rallies 13%; hits record high on strong Q2 resultsBusiness Standard · 27 Oct, 12:30 pm Acutaas Chemicals Opens Korea Plant; Shares Rise 0.50%HDFC Sky · 28 Aug, 12:30 pm Acutaas Chemicals: A compelling business at an unforgiving priceValue Research · 6 Apr, 12:30 pm Acutaas Chemicals posts 70% profit surge in Q1 FY27 on pharma demandscanx.trade · 28 Jul, 8:03 pm Acutaas Chemicals Q1 Results: Multibagger stock falls 6% despite strong Q1, guidance heldCNBC TV18 · 24 Jul, 12:30 pm Why This Pharma Chemicals Company Is Betting On Three Megatrends At OnceNDTV Profit · 30 Jun, 12:30 pm Acutaas Chemicals: The specialty chemicals story the market is re-rating fastThe Indian Express · 18 May, 12:30 pm

About

About Acutaas Chemicals Limited

Acutaas Chemicals Limited is listed on the NSE under the symbol ACUTAAS and belongs to the Healthcare sector.

Company details

Company name: Acutaas Chemicals Limited
NSE symbol: ACUTAAS
BSE scrip code: 543349
ISIN: INE00FF01025
Listed on: NSE, BSE
Series: EQ (normal equity)
Listed on NSE since: 14 Sep 2021
Face value: ₹5 per share
Market lot: 1 share
Shares issued: 8.19 crore
Index: NIFTY 500
Sector (NSE): Healthcare
Industry: Pharmaceuticals: Major
Managing director / CEO: Naresh Patel
Chair: Naresh Patel
Headquarters: Surat, Gujarat, India
Founded: 2004
Employees: 1,713
Financial year: April to March
Results basis: Consolidated
Website: acutaas.com

Peers

Other Healthcare stocks

Prices from NSE via Upstox. Financials from the company's results filed with NSE (XBRL); ratios are our own working. Profile from global-stock-logos (MIT). For information only, not a recommendation to buy or sell.

India, Wall Street, crypto and commodities, live.

Every product, one clear workflow.

Built from data, on the record.

A clearer view of the markets.

Calculators and tools that show the maths.

Read the numbers, not the noise.

Acutaas Chemicals Limited

Today

Ratios

Quarterly results

Revenue and net profit

Profit & loss

Sales, operating profit and net profit

Balance sheet

Equity, debt and assets

Cash flow

Operating, investing and financing cash

Shareholding

Holding over time

Latest (30 Sep 2026)

Dividends & news

Dividends & corporate actions

Board meetings

Filings with NSE

Latest news

About

Company details

Peers